Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.
published in: Cancer Chemotherapy and Pharmacology
date of publication: 2017-10-26
language: English
main subject: glioblastoma
Cites articles 29
Date
Title
Article - wd:Q46008308